Key result
Ribavirin nearly completely inhibits GFP expression driven by a DNA-based FMDV minigenome system.
Why the study?
Picornavirus reverse genetics and minigenome systems using in vitro transcription and RNA transfection are inefficient due to rapid RNA degradation, while mammalian RNA polymerase I and II DNA-based systems are restricted to the nuclear compartment.
Answers are grounded in this paper and cite their sources.
Establishes a novel plasmid DNA-based FMDV minigenome system (pKLS3) that drives intracytoplasmic mRNA transcription and protein translation without requiring in vitro RNA synthesis, offering a biosafe platform for picornavirus antiviral drug screening and vaccine vector development.
Picornaviruses are non-enveloped, single-stranded RNA viruses that cause highly contagious diseases, such as polio and hand, foot-and-mouth disease (HFMD) in human, and foot-and-mouth disease (FMD) in animals. Reverse genetics and minigenome of picornaviruses mainly depend on in vitro transcription and RNA transfection; however, this approach is inefficient due to the rapid degradation of RNA template. Although DNA-based reverse genetics systems driven by mammalian RNA polymerase I and/or II promoters display the advantage of rescuing the engineered FMDV, the enzymatic functions are restricted in the nuclear compartment. To overcome these limitations, we successfully established a novel DNA-based vector, namely pKLS3, an FMDV minigenome containing the minimum cis-acting elements of FMDV essential for intracytoplasmic transcription and translation of a foreign gene. A combination of pKLS3 minigenome and the helper plasmids yielded the efficient production of uncapped-green florescent protein (GFP) mRNA visualized in the transfected cells. We have demonstrated the application of the pKLS3 for cell-based antiviral drug screening. Not only is the DNA-based FMDV minigenome system useful for the FMDV research and development but it could be implemented for generating other picornavirus minigenomes. Additionally, the prospective applications of this viral minigenome system as a vector for DNA and mRNA vaccines are also discussed.
No takes yet. Share an insight, caveat, or question.
Semkum et al. (2021) studied Foot-and-mouth disease virus (FMDV) infection (in vitro model). pKLS3_GFP FMDV minigenome vector co-transfected with helper plasmids (pCAGGS_T7 and pCAGGS_P3), and antiviral testing with ribavirin and rupintrivir vs. Co-transfection with pKLS3_GFP and pCAGGS_T7 alone, single plasmid pKLS3_GFP transfection, negative control (pCAGGS_T7 + pCAGGS_P3), and untreated control for antiviral screening was evaluated on Intracytoplasmic GFP mRNA transcription and translation efficiency (green fluorescent signal intensity and GFP-positive cell counts) and viral growth kinetics (TCID50/mL) (p=<0.05). The DNA-based FMDV minigenome pKLS3 co-transfected with pCAGGS_T7 and pCAGGS_P3 efficiently drove intracytoplasmic GFP expression in BHK-21 cells and was almost completely inhibited by ribavirin.
Synapse has enriched 10 related papers. Consider them for comparative context: